Terms: = Prostate cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
16 results:
1. Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive prostate cancer: A Systematic Review.
Van der Eecken K; Vanwelkenhuyzen J; Deek MP; Tran PT; Warner E; Wyatt AW; Kwan EM; Verbeke S; Van Dorpe J; Fonteyne V; Lumen N; De Laere B; Ost P
Eur Urol Oncol; 2021 Dec; 4(6):914-923. PubMed ID: 34801437
[TBL] [Abstract] [Full Text] [Related]
2. Targeting KDM4B that coactivates c-myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
[No Abstract] [Full Text] [Related]
3. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
4. Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.
Cheng Y; Gao XH; Li XJ; Cao QH; Zhao DD; Zhou JR; Wu HX; Wang Y; You LJ; Yang HB; He YL; Li YR; Bian JS; Zhu QY; Birnbaumer L; Yang Y
Oncogene; 2018 May; 37(22):2953-2966. PubMed ID: 29515233
[TBL] [Abstract] [Full Text] [Related]
5. mycN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
[TBL] [Abstract] [Full Text] [Related]
6. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-myc oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract] [Full Text] [Related]
7. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.
Liu W
Asian J Androl; 2016; 18(4):533-42. PubMed ID: 26975494
[TBL] [Abstract] [Full Text] [Related]
8. NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.
Silva MP; Barros-Silva JD; Vieira J; Lisboa S; Torres L; Correia C; Vieira-Coimbra M; Martins AT; Jerónimo C; Henrique R; Paulo P; Teixeira MR
Genes Chromosomes Cancer; 2016 Apr; 55(4):365-74. PubMed ID: 26799514
[TBL] [Abstract] [Full Text] [Related]
9. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Grönberg H; Neal DE;
EBioMedicine; 2015 Sep; 2(9):1133-44. PubMed ID: 26501111
[TBL] [Abstract] [Full Text] [Related]
10. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic prostate tissue biomarkers of potential clinical use.
Van der Kwast TH
Virchows Arch; 2014 Mar; 464(3):293-300. PubMed ID: 24487790
[TBL] [Abstract] [Full Text] [Related]
12. 8q24 cancer risk allele associated with major metastatic risk in inflammatory breast cancer.
Bertucci F; Lagarde A; Ferrari A; Finetti P; Charafe-Jauffret E; Van Laere S; Adelaide J; Viens P; Thomas G; Birnbaum D; Olschwang S
PLoS One; 2012; 7(5):e37943. PubMed ID: 22666420
[TBL] [Abstract] [Full Text] [Related]
13. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract] [Full Text] [Related]
15. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.
Caruso RP; Levinson B; Melamed J; Wieczorek R; Taneja S; Polsky D; Chang C; Zeleniuch-Jacquotte A; Salnikow K; Yee H; Costa M; Osman I
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):222-7. PubMed ID: 14734473
[TBL] [Abstract] [Full Text] [Related]
16. Small cell carcinoma of the prostate. A case report.
Morikawa T; Kobayashi S; Yamadori I; Okino T; Ohmori M; Kurose M
Int Urol Nephrol; 1993; 25(4):379-84. PubMed ID: 8276566
[TBL] [Abstract] [Full Text] [Related]
